Surgery Partners (NASDAQ:SGRY) Hits New 1-Year Low – Time to Sell?

Shares of Surgery Partners, Inc. (NASDAQ:SGRY) hit a new 52-week low during trading on Monday . The stock traded as low as $13.39 and last traded at $13.24, with a volume of 9685 shares traded. The stock had previously closed at $13.56.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on SGRY. Mizuho decreased their price target on shares of Surgery Partners from $22.00 to $19.00 and set an “outperform” rating for the company in a research note on Thursday, December 18th. Weiss Ratings reissued a “sell (e+)” rating on shares of Surgery Partners in a research report on Monday, December 29th. Barclays dropped their price target on Surgery Partners from $24.00 to $18.00 and set an “equal weight” rating on the stock in a research report on Friday, November 21st. Royal Bank Of Canada decreased their price objective on Surgery Partners from $35.00 to $31.00 and set an “outperform” rating for the company in a report on Tuesday, November 11th. Finally, Benchmark dropped their price objective on shares of Surgery Partners from $35.00 to $30.00 and set a “buy” rating on the stock in a report on Tuesday, November 11th. Seven investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $27.11.

Surgery Partners Stock Performance

The company has a quick ratio of 1.72, a current ratio of 1.88 and a debt-to-equity ratio of 1.10. The company has a market capitalization of $1.75 billion, a PE ratio of -9.99 and a beta of 1.97. The company has a 50-day moving average price of $15.70 and a two-hundred day moving average price of $19.13.

Surgery Partners (NASDAQ:SGRY) last issued its earnings results on Monday, November 10th. The company reported $0.13 EPS for the quarter, missing the consensus estimate of $0.19 by ($0.06). Surgery Partners had a positive return on equity of 2.41% and a negative net margin of 5.21%.The company had revenue of $821.50 million during the quarter, compared to the consensus estimate of $823.55 million. During the same quarter in the prior year, the business earned $0.19 EPS. The firm’s revenue for the quarter was up 6.6% compared to the same quarter last year. Analysts predict that Surgery Partners, Inc. will post 0.67 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of SGRY. Jones Financial Companies Lllp increased its holdings in shares of Surgery Partners by 313.1% in the third quarter. Jones Financial Companies Lllp now owns 1,227 shares of the company’s stock worth $27,000 after purchasing an additional 930 shares during the period. AlphaQuest LLC increased its stake in Surgery Partners by 94.4% in the 2nd quarter. AlphaQuest LLC now owns 2,057 shares of the company’s stock worth $46,000 after acquiring an additional 999 shares during the last quarter. Caitong International Asset Management Co. Ltd raised its holdings in shares of Surgery Partners by 45,640.0% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 2,287 shares of the company’s stock valued at $49,000 after acquiring an additional 2,282 shares in the last quarter. PNC Financial Services Group Inc. boosted its position in shares of Surgery Partners by 128.4% during the 3rd quarter. PNC Financial Services Group Inc. now owns 2,702 shares of the company’s stock valued at $58,000 after acquiring an additional 1,519 shares during the last quarter. Finally, FNY Investment Advisers LLC bought a new stake in shares of Surgery Partners during the 2nd quarter valued at about $115,000.

About Surgery Partners

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.